Irbesartan achieves consistent and effective use over 1 year.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000077405:Irbesartan; D010349:Patient Compliance; D013777:Tetrazoles / Q000627:therapeutic use*; D013997:Time Factors
D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan